Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT06311435 · ClinicalTrials.gov registry record · NA

Utilizing Novel Blood RNA Biomarkers as a Diagnostic Tool in the Identification of Long COVID-19

A NA study of Long COVID, sponsored by MaxWell Clinic.

Recruiting
Registry status
NA
Development phase
224
Enrollment target
3
Study locations

NCT06311435 is a NA study of Long COVID that is actively recruiting participants, run by MaxWell Clinic. The registered enrollment target is 224 participants, below the 2,184-participant average among 50 other Long COVID trials with a reported enrollment target (90% lower). The trial reports 3 study locations across 2 states.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT06311435, a NA study of Long COVID, is actively recruiting participants, sponsored by MaxWell Clinic.

RECRUITING
Registry status
NA
Development phase
224 participants
Enrollment target
3
Study locations

Study Summary

The Primary objective of this study is to determine, using unblinded samples, if it is possible to develop an algorithm for the classification of specific blood RNA from patients with long COVID together and separately from the apparent health normal controls and other medical conditions that share the signs and symptoms of long COVID.

Conditions Studied

Long COVID

Interventions

  • DIAGNOSTIC_TEST RNA Biomarker Blood Test

Study Locations (3)

Tennessee

  • The MaxWell Clinic - Brentwood
  • The MaxWell Clinic - Brentwood

Iowa

  • University of Iowa - Iowa City

Trial Details

FieldValue
Enrollment Target 224 participants
Start Date 2024-03-15
Est. Completion 2026-03-15
Phase NA

Sponsor

MaxWell Clinic

1 total trials

Interested in This Trial?

Full Details on ClinicalTrials.gov ↗

What the Registry Record Tells You About NCT06311435

The ClinicalTrials.gov registry entry for NCT06311435 describes a study currently listed as recruiting, categorized as NA. The registered enrollment target is 224 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 2,184-participant average among 50 other Long COVID trials with a reported enrollment target (90% lower). The listed sponsor is MaxWell Clinic, which has 1 total studies on file at ClinicalTrials.gov.

The record links to 1 condition, with Long COVID appearing as the primary indexed condition, and to 1 intervention - of which RNA Biomarker Blood Test is the first listed.

NCT06311435 reports 3 study locations spanning 2 distinct geographic areas - top geographies include Tennessee, Iowa.

Frequently Asked Questions

What is clinical trial NCT06311435 about?

NCT06311435 is a clinical study titled "Utilizing Novel Blood RNA Biomarkers as a Diagnostic Tool in the Identification of Long COVID-19". The Primary objective of this study is to determine, using unblinded samples, if it is possible to develop an algorithm for the classification of specific blood RNA from patients with long COVID together and separately from the apparent health normal controls and other medical conditions that share ...

What is the current status of trial NCT06311435?

This trial is currently recruiting. It is a NA study. The enrollment target is 224 participants. The study started on 2024-03-15. Estimated completion is 2026-03-15.

What conditions does trial NCT06311435 study?

This clinical trial studies the following conditions: Long COVID.

What interventions are being tested in trial NCT06311435?

The interventions under investigation include: RNA Biomarker Blood Test (DIAGNOSTIC_TEST).

Who is sponsoring clinical trial NCT06311435?

This trial is sponsored by MaxWell Clinic, which has 1 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT06311435 being conducted?

This trial has 3 study locations across Iowa, Tennessee. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Learn More About Clinical Trials

Similar trials for Long COVID

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Explore more on PlainTrial

Long COVID

All registered trials for this condition

Iowa

All trials with a study site in Iowa

Recruiting now

Find trials open to new participants near you

Rankings

Top sponsors, conditions, and phases

Read our methodology - how this data is sourced, computed, and verified.

Related

Browse all → | Rankings →
Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial Editorial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.